04/19/2026
We’re excited about what the future may hold for ibogaine and its potential role in addiction treatment. We’re closely following ongoing research and developments so we can stay informed and continue bringing the most effective, evidence-based options to our patients.
As always, our focus remains on safe, compassionate, whole-person care—and expanding access to treatments that support lasting recovery. 💙
Trump signed an executive order directing federal regulators to accelerate the review of certain psychedelic drugs.